The use of single-cell technologies has rapidly advanced our understanding of baseline immune development and pathologies of early-life, however, there is a pressing need for development and benchmarking of multi-modal platforms that measure parameters beyond mRNA transcripts, and the analytical tools required to integrate these complex datasets.